Literature DB >> 4825623

Plasma 17-hydroxyprogesterone in newborn infants with congenital adrenal hyperplasia and in infants with normal adrenal function.

S M Atherden, A T Edmunds, D B Grant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4825623      PMCID: PMC1648710          DOI: 10.1136/adc.49.3.192

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  8 in total

1.  Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.

Authors:  N D Barnes; S M Atherden
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

2.  Congenital adrenal hyperplasia and other conditions associated with a raised urinary steroid 11-oxygenation index.

Authors:  B E Clayton; R W Edwards; H L Makin
Journal:  J Endocrinol       Date:  1971-06       Impact factor: 4.286

3.  Studies on the deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia.

Authors:  A P Simpoulos; J R Marshall; C S Delea; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

4.  Diurnal variation of plasma 17-hydroxycorticosteroids in children.

Authors:  R C Franks
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

5.  Screening tests for congenital adrenal hyperplasia.

Authors:  R C Franks
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

6.  Difficulties in the diagnosis of the adrenogenital syndrome in infancy.

Authors:  C H Shackleton; F L Mitchell; J W Farquhar
Journal:  Pediatrics       Date:  1972-02       Impact factor: 7.124

7.  Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.

Authors:  S M Atherden; N D Barnes; D B Grant
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

8.  Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia.

Authors:  C A Strott; T Yoshimi; M B Lipsett
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

  8 in total
  1 in total

1.  17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.

Authors:  K von Schnakenburg; F Bidlingmaier; D Knorr
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.